feed,title,long_url,short_url
SeekingAlpha,"Halozyme Therapeutics: A Trailblazer, But With Lukewarm Financials",https://seekingalpha.com/article/4582200,
SeekingAlpha,2022 Berkshire Hathaway Letter To Shareholders: 3 Key Takeaways,https://seekingalpha.com/article/4582199,
